VivoSeq
Dermatology

NODULOCYSTIC ACNE

0

Pipeline Programs

0

Active Trials

0

Companies Involved

NODULOCYSTIC ACNE is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

1

clinical trials

Completed1 · 100%

Trial Activity

Finasteride Treatment of Severe Nodulocystic Acne
Completed·EElorac, Inc.·Phase 2·NCT02502669·106 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)